Newleos Therapeutics is making its debut with $93.5 million aimed at developing safer and more effective neuroscience ...

The study, “The TMEM132B-GABAA receptor complex controls alcohol actions in the brain,” was authored by Guohao Wang, Shixiao Peng, Miriam Reyes Mendez, Angelo Keramidas, David Castellano ...

As a first-in-class GABAA-modulating steroid antagonist (GAMSA), Sepranolone works by normalising the activity of the GABAA receptor by targeting alpha-2 and alpha-4, the receptor subtypes. This ...

The trial results suggest that AP-325, an allosteric GABAA-receptor modulator, rapidly reduces neuropathic pain and provides long-term benefits. Neuropathic pain is a chronic condition linked to an ...

在现代社会，焦虑症已成为了一种常见的心理健康问题。你是否或多或少经历过焦虑的时刻？从紧张的工作到生活中的琐事，焦虑症似乎无处不在。那么，有什么新的突破能够帮助我们对抗这种越来越普遍的心理问题呢？ 近日，Newleos Therapeutics 宣布完成9300万美元的A轮融资，这无疑给焦虑症及相关疾病的治疗领域带来了新的曙光。此轮融资由高盛领投，Novo Holdings、Longwood Fun ...

如今，在一项新的研究中，来自加州大学圣地亚哥分校和德克萨斯大学西南医学中心的研究人员构建了人类大脑中GABA A 受体的详细结构图，揭示了它们是如何组装的，以及药物是如何与它们结合的。相关研究结果近期发表在 Nature 期刊上，论文标题为 “Resolving native GABAA receptor structures from the human brain”。

Taaten kun mudate Devece Roos, haati ijoolleeshee lakkuu lama [ijoollee afur] manatti dhiiftee gabaa deemte. Gaafa deebitu ijoollenshee balaa abiddaa ka'een gubatanii lubbuun darbeera. Ijoollee ...

▎药明康德内容团队编辑近日，Newleos Therapeutics宣布完成超额认购的9300万美元A轮融资，此轮融资由Goldman Sachs领投，Novo Holdings、Longwood Fund、DCVC Bio和Arkin Bio ...